Investor RelationsPress RoomCOVID-19
  1. Home
  2. Laboratory Diagnostics
  3. Drug Testing Diagnostics
  4. Drug Testing Assays
  5. Drugs of Abuse Testing
  6. Compliance Monitoring in Medically Assisted Opioid Addiction Treatment

Detection and monitoring of patients with opioid use disorderCompliance Monitoring in Medically Assisted Opioid Addiction Treatment

    Opioids drug-related deaths
    Opioids account for 69% of deaths due to drug use disorders.

    A full opioid menu

    Drug testing is an effective component in monitoring opioid use disorder (OUD) and helping to reduce overdose risks. Siemens Healthineers offers a comprehensive opioid menu, including EMIT II Plus Methadone, EMIT II Plus Buprenorphine, and ARK EDDP immunoassay tests to assist in the detection and monitoring patients with OUD. Siemens Healthineers also offers the EMIT II Plus Oxycodone, ARK Fentanyl, Tramadol, and Meperidine immunoassay tests for the detection of synthetic and semisynthetic opioids.

    Compliance Monitoring in Medically Assisted Opioid Addiction Treatment: The Syva EMIT II Plus Buprenorphine Assay from Siemens Healthineers